Cleveland Clinic

Researchers

• FCFeixiong Cheng
• NPNathan A Pennell

Running trials

• Not yet recruiting

  Life Expectancy-informed Colorectal Cancer Screening

  NCT07141901· Kathryn Martinez· Source

• Not yet recruiting

  A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS

  NCT07222956· Phase 2· Moein Amin· Source

• Not yet recruiting

  A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis

  NCT07335562· Phase 3· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source

• Not yet recruiting

  Wearable Technology in Heart Failure Patients

  NCT07650669· The Cleveland Clinic· Source

• Not yet recruiting

  Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension

  NCT07218198· The Cleveland Clinic· Source

• Not yet recruiting

  A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies

  NCT07789015· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  Decoding the Neural Mechanisms Underlying Postural Instability and Gait Dysfunction in Parkinson's Disease

  NCT07748962· The Cleveland Clinic· Source

• Not yet recruiting

  Youth Suicide Prevention: CAMS-BI vs. Safety Planning in a Randomized Trial

  NCT07628192· The Cleveland Clinic· Source

• Not yet recruiting

  COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

  NCT07281027· Phase 3· Yale University· Source

• Not yet recruiting

  Dietary Tracking in Heart Failure

  NCT07649148· The Cleveland Clinic· Source

• Not yet recruiting

  A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment

  NCT07926321· Phase 2· Boehringer Ingelheim· Source

• Not yet recruiting

  Metabolic Surgery for Atrial Fibrillation Elimination

  NCT07027969· Phase 4· Ali Aminian· Source

• Not yet recruiting

  A Study to Evaluate Ofirnoflast in Adults With Very Low- to Intermediate-risk Myelodysplastic Syndromes Requiring Red Blood Cell Transfusions

  NCT07738510· Phase 2· Halia Therapeutics, Inc.· Source

• Not yet recruiting

  Neural Correlates of Suicidal Behavior in Youth

  NCT07568054· The Cleveland Clinic· Source

• Recruiting

  Choose Myself (Before) Losing Myself

  NCT07846566· The Cleveland Clinic· Source

• Not yet recruiting

  Signatera Assessment in Early-Stage Endometrial Cancer

  NCT07339384· Natera, Inc.· Source

• Not yet recruiting

  A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.

  NCT06458907· P+F Products + Features USA Inc.· Source

• Recruiting

  A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

  NCT07768189· Phase 3· Corbus Pharmaceuticals Inc.· Source

• Recruiting

  Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)

  NCT07817875· Phase 3· Eli Lilly and Company· Source

• Recruiting

  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  NCT07623161· Phase 3· Takeda· Source

• Recruiting

  A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  NCT07623200· Phase 3· Incyte Corporation· Source

• Recruiting

  Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

  NCT07804186· Phase 3· IDEAYA Biosciences· Source

• Recruiting

  MBA Early Feasibility Study

  NCT07564375· W.L.Gore & Associates· Source

• Recruiting

  Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.

  NCT07798323· Scott Raymond· Source

• Recruiting

  Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation

  NCT07436299· Oslo University Hospital· Source

• Recruiting

  Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD

  NCT07680283· The Cleveland Clinic· Source

• Not yet recruiting

  Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations

  NCT07218575· Phase 2/3· Boston Children's Hospital· Source

• Not yet recruiting

  GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD

  NCT07747805· Phase 2· The Cleveland Clinic· Source

• Recruiting

  A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

  NCT07214376· Pulnovo Medical, Inc.· Source

• Recruiting

  Imaging in Semaglutide Study

  NCT07695454· The Cleveland Clinic· Source

• Recruiting

  HCMR Re-Imaging Study

  NCT07054073· Christopher Kramer· Source

• Recruiting

  A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

  NCT07330258· Bayer· Source

• Recruiting

  VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)

  NCT07390344· W.L.Gore & Associates· Source

• Recruiting

  Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS

  NCT07442747· Phase 2· The Cleveland Clinic· Source

• Recruiting

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· Phase 3· Prilenia· Source

• Recruiting

  Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

  NCT07511361· Phase 2· Kardigan, Inc.· Source

• Recruiting

  Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

  NCT07563881· Phase 3· Rapport Therapeutics Inc.· Source

• Active, not recruiting

  Health-Related Quality of Life and Metabolic Outcomes in PCOS

  NCT07571915· The Cleveland Clinic· Source

• Recruiting

  A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  NCT07101328· Phase 1· Eli Lilly and Company· Source

• Recruiting

  A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

  NCT07553429· Phase 1/2· Boehringer Ingelheim· Source

• Recruiting

  Study of INCA036978 in Participants With Myeloproliferative Neoplasms

  NCT07441694· Phase 1· Incyte Corporation· Source

• Recruiting

  Longitudinal Validation of CIRC Technologies

  NCT07081711· The Cleveland Clinic· Source

• Recruiting

  Humidity Asthma Interventions for Low Socioeconomic Status Children

  NCT07453667· Case Western Reserve University· Source

• Not yet recruiting

  The Canopy Cancer Collective Clinical Registry Protocol

  NCT07605702· Canopy Cancer Collective, LLC· Source

• Recruiting

  A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

  NCT07419295· Phase 3· Merck Sharp & Dohme LLC· Source

• Recruiting

  A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis

  NCT07158242· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

  NCT07293351· Phase 1/2· Bristol-Myers Squibb· Source

• Recruiting

  Healthy Aging in People With Epilepsy Program

  NCT06052605· Anny Reyes· Source

• Recruiting

  Bridging the Gap: Educating Patients on Social Determinants of Health to Improve Epilepsy Surgery Access and Outcomes

  NCT07509190· Anny Reyes· Source

• Recruiting

  A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

  NCT07361497· Phase 3· Bristol-Myers Squibb· Source

Showing 50 of 494.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure20 recruiting
• Lung cancer19 recruiting
• Colorectal cancer13 recruiting
• Ovarian cancer13 recruiting
• Parkinson disease13 recruiting
• Atrial fibrillation11 recruiting
• Coronary artery disease11 recruiting
• Gastric and oesophageal cancer11 recruiting
• High blood pressure11 recruiting
• Obesity10 recruiting
• Bladder cancer9 recruiting
• Epilepsy9 recruiting
• Head and neck cancer9 recruiting
• Liver and biliary tract cancer9 recruiting
• Multiple myeloma9 recruiting
• Liver cirrhosis8 recruiting
• Myeloproliferative neoplasms8 recruiting
• Kidney cancer7 recruiting
• Melanoma7 recruiting
• Pancreatic cancer7 recruiting
• Multiple sclerosis6 recruiting
• Sarcoma6 recruiting
• Stroke6 recruiting
• Acute myeloid leukaemia5 recruiting
• Amyloidosis5 recruiting
• Childhood cancers5 recruiting
• Endometrial cancer5 recruiting
• Myelodysplastic syndromes5 recruiting
• Osteoarthritis5 recruiting
• Peripheral artery disease5 recruiting
• Triple-negative breast cancer5 recruiting
• Aortic aneurysm4 recruiting
• Aortic stenosis4 recruiting
• Chronic lymphocytic leukaemia4 recruiting
• Crohn's disease4 recruiting
• Hypertrophic cardiomyopathy4 recruiting
• Idiopathic pulmonary fibrosis4 recruiting
• Macular degeneration4 recruiting
• Metastatic breast cancer4 recruiting
• Cervical cancer3 recruiting
• Dermatomyositis and polymyositis (myositis)3 recruiting
• Diffuse large B-cell lymphoma3 recruiting
• Fatty liver disease (MASLD/MASH)3 recruiting
• Follicular lymphoma3 recruiting
• Glioblastoma3 recruiting
• Polycystic kidney disease3 recruiting
• Pulmonary arterial hypertension3 recruiting
• Ulcerative colitis3 recruiting
• Acute lymphoblastic leukaemia2 recruiting
• Alzheimer disease2 recruiting
• Asthma2 recruiting
• Chronic kidney disease2 recruiting
• Chronic myeloid leukaemia2 recruiting
• Congenital heart disease2 recruiting
• COPD2 recruiting
• Depression2 recruiting
• Diabetic eye disease2 recruiting
• Essential tremor2 recruiting
• Hepatitis B2 recruiting
• Huntington's disease2 recruiting
• Immune thrombocytopenia (ITP)2 recruiting
• Mantle cell lymphoma2 recruiting
• Myasthenia gravis2 recruiting
• Prostate cancer2 recruiting
• Retinitis pigmentosa2 recruiting
• Sickle cell disease2 recruiting
• Type 1 diabetes2 recruiting
• Ventricular tachycardia2 recruiting
• Alopecia areata1 recruiting
• ALS (motor neurone disease)1 recruiting
• Aplastic anaemia1 recruiting
• Autism1 recruiting
• Barrett's oesophagus1 recruiting
• Bipolar disorder1 recruiting
• Brain aneurysm1 recruiting
• CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
• Dilated cardiomyopathy1 recruiting
• Fabry disease1 recruiting
• Gastroparesis1 recruiting
• Gaucher disease1 recruiting
• Glaucoma1 recruiting
• Hearing loss1 recruiting
• Hepatitis C1 recruiting
• Hodgkin lymphoma1 recruiting
• Mesothelioma1 recruiting
• Migraine1 recruiting
• Myocarditis1 recruiting
• Polycystic ovary syndrome1 recruiting
• Pompe disease1 recruiting
• Psoriasis1 recruiting
• Psoriatic arthritis1 recruiting
• Rheumatoid arthritis1 recruiting
• Sarcoidosis1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting
• Thalassaemia1 recruiting
• Thyroid cancer1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Terminated

  AcoArt Litos PCB Below-the-knee Global Trial

  NCT06330493· Acotec Scientific Co., Ltd· Source

• Terminated

  ENABLE-HCM - AI-ENabled Echocardiography With Ultrasound Beyond the Echo Lab for Better HCM Imaging and Expanded Access

  NCT07155434· UltraSight· Source

• Completed

  A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

  NCT06881836· Phase 2· Ono Pharmaceutical Co., Ltd.· Source

• Completed

  RCT of VR Therapy for IBS

  NCT06687616· Christopher Almario· Source

• Completed

  REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

  NCT06788535· Phase 3· Sharmila Dorbala· Source

• Completed

  Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

  NCT06604442· Phase 4· Blue Earth Diagnostics· Source

• Withdrawn

  Efficacy of Virtual Reality (VR) for Irritable Bowel Syndrome

  NCT06257472· Anthony Lembo· Source

• Terminated

  ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

  NCT06418711· Phase 3· Mannkind Corporation· Source

• Recruiting

  CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction

  NCT06258447· BioCardia, Inc.· Source

• Completed

  Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy

  NCT06533527· Phase 4· The Cleveland Clinic· Source

• Completed

  Nutrition Outreach and Understanding: Research In Serving Hearts Through Healthy Eating And Tailored Support

  NCT06460272· Amanda Shallcross· Source

• Withdrawn

  Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations

  NCT06080165· Phase 1/2· Stanford University· Source

• Terminated

  Safety of Bryostatin in Patients With MS

  NCT06190912· Phase 1· Robert Fox· Source

• Terminated

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata

  NCT06444451· Phase 2· Sanofi· Source

• Completed

  MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

  NCT06212466· Genetesis Inc.· Source

• Withdrawn

  SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery

  NCT05104229· Phase 3· Stefan Holubar MD MS FACS, FASCRS· Source

• Terminated

  NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

  NCT06299163· Phase 1· Numab Therapeutics AG· Source

• Recruiting

  Platform Clinical Study for Conquering Scleroderma

  NCT06195072· Phase 2· Scleroderma Research Foundation, Inc.· Source

• Completed

  A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer

  NCT06188559· Phase 2· Eisai Inc.· Source

• Completed

  Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer

  NCT06235099· Phase 3· Curium US LLC· Source

• Completed

  Treatment for Migraine and Mood

  NCT05576467· Amanda Shallcross· Source

• Completed

  RECOVER-AUTONOMIC Platform Protocol

  NCT06305780· Phase 2· Kanecia Obie Zimmerman· Source

• Completed

  Microbial Metabolites and Outcomes of Pregnancy Study

  NCT06362356· The Cleveland Clinic· Source

• Completed

  A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes

  NCT05901831· Phase 3· Bayer· Source

• Withdrawn

  Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN

  NCT05743270· Phase 2· Replimune, Inc.· Source

• Completed

  Testing the Effectiveness of WW Clinic GLP1

  NCT06034457· The Cleveland Clinic· Source

• Completed

  Using Shared Decision Making to Improve Kidney Transplantation Rates

  NCT06141499· Columbia University· Source

• Terminated

  Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

  NCT06153420· Phase 2· CinPhloro Pharma, LLC· Source

• Recruiting

  Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

  NCT05696626· Phase 3· LeonaBio· Source

• Completed

  3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair

  NCT06008613· The Cleveland Clinic· Source

• Terminated

  Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL

  NCT05883449· Phase 2· Affimed GmbH· Source

• Completed

  HEAL-LAA Clinical Trial

  NCT05809596· Boston Scientific Corporation· Source

• Completed

  The Impact of Exercise on Subthalamic Nucleus Neural Activity in Parkinson's Disease

  NCT05905302· Jay Alberts· Source

• Completed

  Identifying the Neural Signature of Exercise to Advance Treatment of PD Cognitive Declines

  NCT05972759· The Cleveland Clinic· Source

• Completed

  STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease

  NCT05843578· Phase 2· Agomab Spain S.L.U.· Source

• Completed

  RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

  NCT05595369· Phase 2· Kanecia Obie Zimmerman· Source

• Completed

  A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

  NCT05936151· Phase 2· Eli Lilly and Company· Source

• Terminated

  A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia

  NCT05886491· Phase 1/2· Takeda· Source

• Terminated

  Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®

  NCT05900050· Phase 2· Genfit· Source

• Terminated

  Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

  NCT05860296· Phase 1/2· SignalChem Lifesciences Corporation· Source

• Completed

  A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

  NCT05882045· Phase 3· Eli Lilly and Company· Source

• Completed

  PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation

  NCT05639751· Phase 1· Prelude Therapeutics Incorporated· Source

• Completed

  RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies

  NCT05869669· Phase 2· EIP Pharma Inc· Source

• Completed

  The CARDIO-TTRansform Scintigraphy Sub-study

  NCT06073587· Ionis Pharmaceuticals, Inc.· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis

  NCT05832151· Phase 2· CinDome Pharma, Inc.· Source

• Completed

  A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen

  NCT05769608· Phase 2· Mineralys Therapeutics Inc.· Source

• Completed

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· Phase 2· Janssen Research & Development, LLC· Source

• Terminated

  A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms

  NCT05787496· Phase 1· NextCure, Inc.· Source

• Terminated

  A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM

  NCT05370508· Phase 1/2· SonALAsense, Inc.· Source

• Completed

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· Phase 3· Bayer· Source

Showing 50 of 207.

Conditions

Diseases this institution publishes on or runs trials for.

• Heart failure419 works · 43 trials
• Stroke356 works · 19 trials
• Obesity274 works · 19 trials
• Atrial fibrillation222 works · 19 trials
• Alzheimer disease130 works · 6 trials
• Prostate cancer119 works · 17 trials
• Epilepsy118 works · 17 trials
• Type 2 diabetes117 works · 8 trials
• Lung cancer114 works · 55 trials
• Multiple sclerosis111 works · 16 trials
• Parkinson disease107 works · 27 trials
• Chronic kidney disease106 works · 12 trials
• Bladder cancer98 works · 20 trials
• Crohn's disease91 works · 16 trials
• Multiple myeloma86 works · 23 trials
• Kidney cancer81 works · 21 trials
• Asthma78 works · 6 trials
• Melanoma77 works · 20 trials
• Amyloidosis77 works · 14 trials
• Colorectal cancer76 works · 32 trials
• Liver and biliary tract cancer75 works · 16 trials
• Coronary artery disease70 works · 17 trials
• Osteoarthritis67 works · 11 trials
• COPD62 works · 5 trials
• Sarcoma59 works · 19 trials
• Ulcerative colitis58 works · 10 trials
• Glioblastoma57 works · 11 trials
• Acute myeloid leukaemia57 works · 19 trials
• Hypertrophic cardiomyopathy55 works · 11 trials
• Congenital heart disease49 works · 3 trials